CTRI/2022/07/043679Other4 期
Antihistamines for treatment of Long COVID â?? A placebo controlled double blinded Randomized Controlled Trial
Dr Arjun M C0 个研究点目标入组 8 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- Other
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Adults diagnosed with COVID-19 and presenting with Long COVID symptoms after 3 months of COVID-19 diagnosis (Diagnosed with RTPCR or RAT only)
排除标准
- •Pregnant and lactating women
- •Patients who are severely ill, bedridden or cannot follow up in hospital
- •Patients having Diagnosed Liver or kidney diseases
- •Those who do not consent
研究者
相似试验
已完成
不适用
actoferrin in the treatment of Long COVIDNL-OMON50577ongziekten72
招募中
不适用
actoferrin in the treatment of Long COVIDong COVIDNL-OMON21473Stichting O&O Franciscus Gasthuis & Vlietland72
撤回
4 期
Systemic antihistamines in the treatment of attention-deficit/hyperactivity disorder (ADHD): a pilot study.allergyADHDattention deficit and hyperactivity disorder1000170810009841NL-OMON42065Medisch Centrum Leeuwarden60
尚未招募
不适用
Antihistamines in the treatment of ADHD and allergy.attention-deficit/hyperactivitydisorder (ADHD), atopy, allergy, eczema, asthma, allergic rhinitisNL-OMON24270Dr. T.W. de VriesMedical Center Leeuwarden PediatricsP.O. BOX 8888901 BR LeeuwardenTel. 058-2863385Fax. 058-2863390e-mail: tjalling.de.vries@znb.nl70
暂停
2 期
Convalescent Antibody-Mediated Treatment of COVID-19 Infections in Patients with B-cell dysfunction, a Randomized Trial (COVID-Compromise Study).NL-OMON51203Academisch Medisch Centrum86